baber/WOPTO huggingface dataset:
Patent EP-2370928-A1 (EP)
Title: Contrôle d'accès
Inventor: BURBRIDGE TREVOR
IPC: G06F21/60
Filed: 2009-12-18
Abstract: L'invention porte sur des procédés et un appareil pour mettre à jour une mémoire de politiques associée à un point de décision de politique d'un système de contrôle d'accès, le point de décision de politique étant agencé pour fournir, en réponse à des requêtes de décision reçues, des décisions de contrôle d'accès en fonction d'une ou plusieurs politiques stockées dans ladite mémoire de politiques, chaque politique spécifiant une décision de contrôle d'accès prédéterminée devant être fournie en réponse à une requête d'accès particulière faite par rapport à un attribut particulier ou une combinaison d'attributs, le point de décision de politique étant associé à au moins un point d'application de politique agencé pour mettre en œuvre un contrôle d'accès conformément à des décisions de contrôle d'accès fournies par ledit point de décision de politique en réponse à des requêtes de décision soumises par ledit point d'application de politique, ledit point d'application de politique étant associé à une mémoire d'attributs fournissant des données relatives à des attributs par rapport auxquels des requêtes d'accès ont précédemment été faites par l'intermédiaire dudit point d'application de politique.
Patent EP-2337567-A1 (EP)
Inventor: SIWICKI ANDRZEJ KRZYSZTOF
IPC: A61K47/20
Filed: 2009-08-05
Abstract: The preparation contains preferably up to 30% (especially 15-25%) by weight of methisoprinol. Methisoprinol is preferably dissolved in water. Another form is a solution of methisoprinol in polyhydric alcohol, where the alcohol is propylene glycol or sorbitol. The preparation also contains excipients and additional ingredients. Methisoprinol has also been proved effective against papillomas.
Patent EP-2337692-A1 (EP)
Title: Appareil d'insertion d'objets distincts dans des enveloppes et procédés correspondants
Inventor: KERN PETER
IPC: B43M3/04
Filed: 2009-01-09
Abstract: La présente invention concerne un appareil (100) destiné à insérer un papier ou un objet de type film (120) ou bien une pile de tels objets (120) dans une enveloppe (130). Un appareil d’alimentation (110) déplace l’objet (120) vers un poste d’insertion et un tambour à dépression (150) présente une surface (170) conçue pour venir au contact de l'enveloppe (130) et la déplacer vers le poste d'insertion. Un élément rampe (210) est accouplé au tambour à dépression (150) et est conçu pour soutenir une partie tête (130f) de l’enveloppe (130) lorsque cette dernière (130) se déplace vers le tambour à dépression (150).
Patent EP-2344059-A1 (EP)
Title: Implant minimalement invasif et système de sertissage
Inventor: DELL OCA ALBERTO A FERNANDEZ
IPC: A61B17/82
Filed: 2009-07-22
Abstract: La présente invention concerne un dispositif permettant de traiter un os. Ledit dispositif comprend un bloc de câble incluant une première lumière, qui s'étend depuis une première ouverture proximale dans une surface proximale dudit bloc de câble jusqu'à une première ouverture distale dans une surface distale de celui-ci. Cette première lumière est configurée pour recevoir un câble de cerclage qui inclut une extrémité élargie. Le bloc de câble inclut en outre une seconde lumière, qui s'étend depuis une seconde ouverture proximale dans la surface proximale jusqu'à une seconde ouverture distale dans la surface distale, et qui est configurée pour accueillir une partie du câble s'étendant depuis l'extrémité élargie tout en empêchant ladite extrémité élargie de passer à travers. Ledit bloc de câble inclut une fente qui relie des parties distales de la première lumière et de la seconde lumière et qui est au moins aussi large que la seconde lumière, en association avec un élément de blocage sertissable incluant un canal configuré pour recevoir la partie du câble qui s'étend depuis l'extrémité élargie.
Patent EP-2323734-A1 (EP)
Title: Dérivés de cyclopropylchromène en tant que modulateurs du récepteur alpha-2c
Inventor: YU YOUNONG
IPC: C07D405/14
Filed: 2009-08-03
Abstract: Dans de nombreux modes de réalisation, la présente invention concerne une nouvelle classe de dérivés de cyclopropylchromène utilisés en tant que modulateurs du récepteur adrénergique a2C, des procédés de préparation de ces composés, des compositions pharmaceutiques contenant un ou plusieurs de ces composés, des procédés de préparation de formulations pharmaceutiques comprenant un ou plusieurs de ces composés, et des méthodes de traitement, de prévention, d'inhibition ou d'amélioration d'un ou de plusieurs états associés aux récepteurs adrénergiques a2C employant ces composés ou compositions pharmaceutiques.
Patent EP-2359646-A1 (EP)
Inventor: COUTELOU OLIVIER
IPC: H04W88/16
Filed: 2009-12-03
Abstract: The invention relates to a communication device for wireless communication networks having one or more frequencies. The device comprises a control module (23) for the transmission of repetitive messages (45, 55) to reception devices having at least two reception frequencies (Fl, F2, F3), at least one reception frequency being common with the transmission frequency (F2) of the repetitive messages. Upon reception of the repetitive messages, a polling module (5) changes the reception frequency according to at least one polling period (TS). At least one predetermined transmission period (TE) has a value different from the said polling periods. The communication system comprises a device for transmitting and receiving the repetitive messages. The method processes the transmission and the reception of the repetitive messages in a multi-frequency network.
Patent EP-2516401-A1 (EP)
Inventor: KOFTIS THEOHARIS V
IPC: C07D215/18
Filed: 2009-12-23
Abstract: The present invention relates to an improved process for the preparation of Montelukast and pharmaceutical acceptable salts or derivatives thereof, in particular to a process for large scale production of Montelukast and salts thereof in high yield and high purity and pharmaceutical preparations containing said compounds.
Patent EP-2328632-A1 (EP)
Title: Procédés et dispositifs permettant de désobstruer des tubes médicaux
Inventor: BOYLE JR EDWARD M
IPC: B08B9/043
Filed: 2009-06-02
Abstract: Dans divers modes de réalisation, l'invention concerne un dispositif permettant de désobstruer un tube médical tel qu'un tube thoracique. Dans certains modes de réalisation, le dispositif comprend un fil de guidage partant d'un récipient de drainage, que l'on peut faire avancer ou reculer dans un tube médical tel qu'un tube pulmonaire via un actionneur. Ce fil est actionné de manière à maintenir un champ stérile dans le tube pulmonaire et la voie d'aspiration connexe. Sont également décrites des méthodes permettant de dégager un tube médical au moyen d'un tel dispositif.
Patent EP-2383187-A1 (EP)
Inventor: MARTINO GONZALEZ ESTEBAN
IPC: B64F5/00
Filed: 2009-12-29
Abstract: A method of designing an aircraft component formed by a number of elements (j), that includes a phase to estimate the effect of a variation of a design variable on the component weight comprising the following steps: a) providing the main primary structure basic data of the aircraft component and the Reserve Factors (RFij) associated to its design criteria (i); b) obtaining a breakdown of the component weight by said design criteria (i) using a fictitious weight (mefRFij) calculated taking into account the relative importance of their critical design criteria; c) obtaining the weight effect of a design variable variation, recalculating firstly the new Reserve Factors (RFij) using suitable functions for the variation of said Reserve Factors (RFij) vs. the variation of said design variable and, secondly, recalculating the component weight using suitable functions for the variation of the element (j) dimensions vs. the variation of said Reserve Factors (RFij).
Patent EP-2344450-A1 (EP)
Title: Dérivés d'arylsulfone substitués comme bloqueurs des canaux calciques
Inventor: CHAKRAVARTY PRASUN K
IPC: C07C315/00
Filed: 2009-09-21
Abstract: L'invention porte sur une série de dérivés d'arylsulfone substitués représentés par la formule I, ou sur des sels pharmaceutiquement acceptables de ceux-ci. Des compositions pharmaceutiques comprennent une quantité efficace des présents composés, soit individuellement, soit en combinaison avec un ou plusieurs autres composés thérapeutiquement actifs, et un support pharmaceutiquement acceptable. Des procédés de traitement d'états associés à, ou provoqués par, une activité des canaux calciques, comprenant, par exemple, une douleur aiguë, une douleur chronique, une douleur viscérale, une douleur inflammatoire, une douleur neuropathique, une incontinence urinaire, une rougeur, une dermatite allergique, l'épilepsie, une neuropathie diabétique, le syndrome du côlon irritable, une dépression, l'anxiété, la sclérose en plaque, un trouble du sommeil, un trouble bipolaire et une attaque, consistent à administrer une quantité efficace des présents composés, soit individuellement, soit en combinaison avec un ou plusieurs autres composés thérapeutiquement actifs.
Patent EP-2333766-A1 (EP)
Inventor: OGAWA MASANORI
IPC: G10K11/16
Filed: 2009-03-18
Abstract: The object of the present invention is to provide a sound absorbing material having a light weight and excellent sound absorbing performance, and a sound absorbing material consisting of a fiber sheet made of fibers containing at least 50% by mass of a porous fiber having many minute pores, each minute pore opening onto the surface of the porous fiber, and having an airflow resistance in the range of between 0.05 and 3.0 kPa·s/m. 
     The porous fiber having many minute pores, each one opening onto the surface of the porous fiber, has air-permeability, and so a sound absorbing property in itself, and a sheet made of the porous fiber having air-permeability and sound absorbing property has even further sound absorbing properties created by the spaces between the porous fibers, resulting in the sheet becoming a sound absorbing material with extremely great sound absorbing efficiency.
Patent EP-2342568-A1 (EP)
Title: Cadhérine-17 en tant que marqueur de diagnostic et cible thérapeutique pour un cancer du foie
Inventor: LUK MOONCHING JOHN
IPC: G01N33/574
Filed: 2009-10-09
Abstract: L'invention porte sur des compositions et des procédés de diagnostic, traitement et/ou prévention des cancers caractérisés par une surexpression de CDH 17 sur la base de la détection de CDH 17 ou sur l'utilisation de CDH 17 en tant que cible pour une intervention thérapeutique ou une intervention prophylactique. Les procédés de diagnostic et/ou de surveillance des cancers du foie à l'aide de l'expression de CDH 17 mettent en jeu la détection et/ou la quantification de la protéine CDH 17 ou d'acides nucléiques codant (ADN ou ARN) dans un échantillon biologique tel que de l'urine provenant du sujet. La présence de la molécule CDH 17 dans des tissus hépatiques dénote l'incidence d'un cancer du foie. On peut utiliser les procédés pour détecter des formes soit solubles soit tronquées de CDH 17 à l'aide d'anticorps spécifiques pour régions uniques recouvrant les domaines 1 et 2 (D1-D2) de la CDH 17 tronquée et sécrétée. On a également développé des procédés de traitement des cancers du foie à l'aide de CDH 17 en tant que cible et de sensibilisation de cellules avec une expression aberrante de CDH 17. Les procédés comprennent la suppression ou l'inactivation de l'expression de CDH 17 par l'administration d'une quantité efficace d'un inhibiteur de CDH 17. La suppression ou l'inactivation de CDH 17 réduit en dimension des tumeurs hépatiques issues de cellules tumorales qui présentent une expression accrue de CDH 17 et rendent les cellules tumorales du foie plus sensibles à certains médicaments de chimiothérapie, tels que Taxol, Epirubicine et Carboplatine, et thérapie génique à base de p53.
Patent EP-2351741-A1 (EP)
Inventor: TANAKA HIROYUKI
IPC: C09K19/54
Filed: 2009-10-14
Abstract: The invention provides a liquid crystal compound having general physical properties necessary for a compound, stability to heat, light or the like, a wide temperature range of a liquid crystal phase, a high clearing point, an excellent compatibility with other liquid crystal compounds, a large refractive index anisotropy and a large dielectric anisotropy. The invention provides a liquid crystal composition that includes the liquid crystal compound and a liquid crystal display device that contains the liquid crystal composition. 
     The compound provided is represented by formula (1):
     
wherein, for example, R 1  is alkyl having 1 to 20 carbons; at least one of the ring A 1  to the ring A 6  is pyrimidine-2,5-diyl or pyridine-2,5-diyl and the others are 1,4-cyclohexylene or 1,4-phenylene; Z 1  to Z 6  are a single bond; L 1  to L 4  is hydrogen or halogen; X 1  is hydrogen, halogen, -C≡N or alkyl having 1 to 10 carbons; and 1, m, n, o, p and q are 0 or 1 and 1+m+n+o+p+q is 3.
Patent EP-2357087-A1 (EP)
Inventor: ANDO JITSUHIKO
IPC: B41J2/325
Filed: 2009-11-13
Abstract: A duplex printing method for printing on the both sides of a roll sheet by a thermal transfer method comprises a first print step for superimposing and pressing a thermal transfer sheet (7a) and a roll sheet (3) between a platen roller (13a) and a thermal head (11a) in such a manner that the bottom surface of the thermal transfer sheet (7a) touches the top surface of the roll sheet (3) and the bottom surface of the roll sheet (3) touches the platen roller (13a), and printing an image on the top surface of the roll sheet (3) while conveying the thermal transfer sheet (7a) and the roll sheet (3); and a second print step for superimposing and pressing a thermal transfer sheet (7b) and the roll sheet (3) between a platen roller (13b) and a thermal head (11 b) in such a manner that the top surface of the thermal transfer sheet (7b) touches the bottom surface of the roll sheet (3) and the top surface of the roll sheet (3) touches the platen roller (13b), and printing an image on the bottom surface of the roll sheet while conveying the thermal transfer sheet (7b) and the roll sheet (3).
Patent EP-2365822-A1 (EP)
Inventor: CAMIRE RODNEY M
IPC: C07K14/745
Filed: 2009-11-23
Abstract: Compositions and Methods for the treatment of coagulation disorders using Factor V variants are provided. Preferred disorders include hemophilia A and B.
Patent EP-2254131-A1 (EP)
Inventor: MIYATA KOJI
IPC: H02K15/03
Filed: 2009-11-27
Abstract: The invention provides a sintered Nd base magnet which is free of a decline of remanence, has a high coercive force, especially at the edges thereof, is unsusceptible to demagnetization even at high temperature, and is suited for use in permanent magnet rotary machines.
Patent EP-2359885-A1 (EP)
Inventor: LEE SEUNG SEOB
IPC: B81C1/00
Filed: 2009-03-09
Abstract: The present invention relates to a microneedle which is configured to have a vertical groove formed along a side thereof so as to serve as a fluid passageway and in which an upper portion of an outer edge of each of a pair of projections forming both sidewalls of the vertical groove is formed to be narrower than an outer edge of the body defining a bottom of the vertical groove and to be shorter than an upper portion of the body, a manufacturing method thereof, and an out-of-plane microneedle sheet to which the microneedle is applied. The microneedle can be provided which allows active ingredients or blood to effectively flow into or out of the human body through a space between the surface of a microneedle and a punctured skin texture or through the vertical groove.
Patent EP-2208704-A1 (EP)
Inventor: SCHULZ ECKHARD
IPC: B66F9/075
Filed: 2010-01-08
Abstract: The arm (10) has a distance sensor (22) arranged adjacent to a carrier arm (14) in a bore hole (20) of a fork face (12), and detecting presence of a load on the carrier arm. The sensor is connected with a communication unit at the fork surface for transmitting a sensor signal to an industrial truck. The sensor is connected with a control unit (28) that is attached to the fork surface. The control unit is connected with an antenna (38) at the fork surface or with the truck via a data line. A radio frequency identification antenna (34) is integrated in a front region of the carrier arm.
Patent EP-2218338-A1 (EP)
Inventor: BEKERS MARION
IPC: A23L1/18
Filed: 2010-01-28
Abstract: Particulate cereal product comprises expanded cereal powder, where alkali carbonate is immobilized on the cereal powder particulate. Independent claims are also included for: (1) producing the particulate cereal product, comprising: (i) providing expanded cereal powder, (ii) contacting an alkali carbonate with the expanded cereal powder in presence of a binder to obtain the particulate cereal product with immobilized alkali metal carbonate and (iii) optionally drying the particulate cereal product; and (2) preparing a food mixture comprising (ia) providing the particulate cereal product, (iib) contacting the particulate cereal product with at least one further food component.
Patent EP-2202979-A1 (EP)
Inventor: MORIYA YOSHIMI
IPC: H04N21/435
Filed: 2003-03-20
Abstract: Multimedia content containing moving pictures and audio is divided into multiple scenes and metadata is generated for each of the scenes obtained as a result of the division. It is possible to generate metadata containing scene structure informationmetadata that describes the hierarchical structure of the content in addition to scene section information and titles. Also, in order to perform re-generation of metadata more appropriately, the metadata re-generation is performed using metadata optimization hint information describing each type of descriptor contained in the metadata.
Patent EP-2275141-A1 (EP)
Inventor: NAKAGAMI HIROAKI
IPC: A61K31/522
Filed: 2000-03-16
Abstract: A granular pharmaceutical composition, comprising (A) a drug having disagreeable taste; (B) one or more of waxy substances selected from the group consisting of hydrogenated castor oil, hydrogenated soybean oil, hydrogenated rape seed oil, hydrogenated cotton seed oil, camauba wax, white bees wax, beef tallow, stearyl alcohol, cetanol, polyethylene glycol, stearic acid, parmitic acid, mono-fatty acid glycerin ester, tri-fatty acid glycerin ester and fatty acid sucrose ester; and (C) erythritol,  characterized in that  the composition thereof does not cohere in water and has a dosage form of a granule, powder or capsule.
Patent EP-2287742-A1 (EP)
Inventor: MCDONALD-MAIER KLAUS
IPC: G06F11/36
Filed: 2002-08-02
Abstract: The program-controlled unit has a core (C) for execution of the programs and debug resources (OCDS), for monitoring and influencing the program execution within the core and influencing other components (P1-Pn, S1-Sn) of the program-controlled unit and/or the cooperation of these components with one another and with the core.
Patent EP-2283825-A1 (EP)
Inventor: DANSEREAU RICHARD JOHN
IPC: A61K31/675
Filed: 2005-04-14
Abstract: Oral dosage forms of a bisphosphonate comprised of a safe and effective amount of a pharmaceutical composition comprising a bisphosphonate, a chelating agent, and means for effecting delayed release of the bisphosphonate and the chelating agent in the lower gastrointestinal tract provide delivery of the pharmaceutical composition to the lower gastrointestinal tract of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. 
     The present invention substantially alleviates the interaction between bisphosphonates and food or beverages, which interaction results in the bisphosphonate active ingredient not being available for absorption. The resulting oral dosage form may thus be taken with or without food. Further, the present invention effects delivery of the bisphosphonate and the chelating agent to the lower GI tract, substantially alleviating the upper GI irritation associated with bisphosphonate therapies. These benefits simplify previously complex treatment regimens and can lead to increased patient compliance with bisphosphonate therapies.
Patent EP-2287247-A1 (EP)
Inventor: YAMASHITA KAZUYUKI
IPC: C08L23/14
Filed: 2004-12-17
Abstract: An objective of the invention is to provide a resin composition for injection molding a microproduct which enables precise transfer of micromachined features of a stamper or a mold shape at a temperature and a pressure equal to or lower than those of general injection molding, and a microproduct using the resin composition. 
     A polypropylene-based resin and a hydrogenated derivative of a block copolymer shown by the general formula "X-Y" is included. 
     In this case, polymer block X represents a polymer block immiscible with the polypropylene-based resin, and polymer block Y represents an elastomeric polymer block of a conjugated diene.
Patent EP-2243698-A1 (EP)
Inventor: FURUYA KENTARO
IPC: B63H20/12
Filed: 2010-03-08
Abstract: A steering apparatus whereby the steering load is equal even when the left and right steering angles are large when an outboard motor is steered to the left and right via a swivel shaft (44). A connecting hole (37) of a steering plate (27) is provided at a position spaced from a center line (45) of the steering plate so that equal angles (β3, β4) are formed by a first straight line (51), joining the center of the swivel shaft (44) and the connecting hole, and a second straight line (52), joining the connecting hole and a link hole (33) formed in a steering rod (35).
Patent EP-2213247-A1 (EP)
Inventor: WHITE JOHN
IPC: A61B17/00
Filed: 2006-04-28
Abstract: Methods and apparatus are disclosed for sealing a puncture or incision formed percutaneously in tissue separating two internal portions of the body of a living being with an anchor, a sealing plug and a filament connecting the anchor and sealing plug. The methods and apparatus provide for automatic tamping and/or cinching of the scaling plug when the apparatus is withdrawn from the puncture site. The automatic tamping and/or cinching may be facilitated by retracting a procedure sheath without moving the sealing plug or a tamping assembly.
Patent EP-2375622-A1 (EP)
Inventor: PERRINE JEROME
IPC: G06F21/00
Filed: 2010-04-08
Abstract: The present invention provides a method and an apparatus for encrypting and decrypting digital information while imparting a high level of security on the encrypted digital information. A mixed-mode digital-analogue encryption and decryption technique is proposed, which minimises the probability of an unintended recipient of the thus encrypted information being able to decrypt the information using known reverse engineering techniques.
Patent EP-2242330-A1 (EP)
Inventor: SNOW TOM
IPC: H05B6/68
Filed: 2010-04-09
Abstract: The method involves executing a heating cycle by a microwave oven, and proposing three control modes by a control unit of the oven, where the control modes are repetition of the cycle, prolongation of the cycle and stopping of the oven. An input signal corresponding to a selection of one of the control modes is acquired, and the selected control mode is executed. Parameters of the executed heating cycle are automatically stored. An independent claim is also included for a microwave oven comprising a control unit that is provided with a microprocessor.